Over 50% of skin cancers occur in those over 60. This population also has a high incidence of risk for surgical procedures due to various disorders like diabetes and cardiac diseases that can slow the healing process.

The traditional treatment path for non-melanoma skin cancer has been Mohs surgery. This surgery involves a series of excisions of cancerous tissue and surrounding healthy tissue until the cancer can no longer be detected. This procedure can lead to substantial cosmetic surgery requirements and a drawn-out healing process which can result in infection.

Sensus Healthcare recognized a need for a different solution for non-melanoma skin cancer treatment for those who have a high surgery risk. Because 80 percent of skin cancers occur in the head and neck regions, where surgery would require great tissue loss and significant cosmetic repair after surgery, Sensus looked to a 50-year proven technique, known as low energy radiotherapy which goes no deeper than the thickness of the skin to effectively treat non-melanoma skin cancer.

Compared to the legacy orthovoltage systems that were used in the dermatology and radiation oncology practices, Sensus offers the SRT-100™ as a modern solution, which is a safe, effective, and reliable technology. The SRT-100™ meets today’s clinical and market needs by employing state-of-the-art technology for efficient and effective treatment of non-melanoma skin cancers.